The number of patients with end-stage heart failure treated by a left ventricular assist device (LVAD) is dramatically increasing, because the LVAD has been widely accepted for its clinical results. According to the initiation of destination therapy, the prevalence of malignancy in patients with an LVAD is estimated to increase. In patients with LVADs, abdominal surgery for visceral malignancy is associated with technical difficulties because of the presence of an LVAD pump or the driveline which is located transversely in the preperitoneal space. Herein, we describe the technical management for complete resection of gastric cancer in a patient with an LVAD.
机构:
Baylor Coll Med, Ctr Artificial Organ Dev, Michael E DeBakey Dept Surg, Div Transplant Surg & Assist Devices, Houston, TX 77030 USABaylor Coll Med, Ctr Artificial Organ Dev, Michael E DeBakey Dept Surg, Div Transplant Surg & Assist Devices, Houston, TX 77030 USA
Furukawa, K
Motomura, T
论文数: 0引用数: 0
h-index: 0
机构:
Baylor Coll Med, Ctr Artificial Organ Dev, Michael E DeBakey Dept Surg, Div Transplant Surg & Assist Devices, Houston, TX 77030 USABaylor Coll Med, Ctr Artificial Organ Dev, Michael E DeBakey Dept Surg, Div Transplant Surg & Assist Devices, Houston, TX 77030 USA
Motomura, T
Nosé, Y
论文数: 0引用数: 0
h-index: 0
机构:
Baylor Coll Med, Ctr Artificial Organ Dev, Michael E DeBakey Dept Surg, Div Transplant Surg & Assist Devices, Houston, TX 77030 USABaylor Coll Med, Ctr Artificial Organ Dev, Michael E DeBakey Dept Surg, Div Transplant Surg & Assist Devices, Houston, TX 77030 USA